These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 24699378)

  • 1. Activation of liver X receptor alleviates ocular inflammation in experimental autoimmune uveitis.
    Yang H; Zheng S; Qiu Y; Yang Y; Wang C; Yang P; Li Q; Lei B
    Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2795-804. PubMed ID: 24699378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of liver X receptor protects inner retinal damage induced by N-methyl-D-aspartate.
    Zheng S; Yang H; Chen Z; Zheng C; Lei C; Lei B
    Invest Ophthalmol Vis Sci; 2015 Jan; 56(2):1168-80. PubMed ID: 25613943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amelioration of amyloid β-induced retinal inflammatory responses by a LXR agonist TO901317 is associated with inhibition of the NF-κB signaling and NLRP3 inflammasome.
    Lei C; Lin R; Wang J; Tao L; Fu X; Qiu Y; Lei B
    Neuroscience; 2017 Sep; 360():48-60. PubMed ID: 28760679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of liver X receptor α protects amyloid β
    Dai B; Lei C; Lin R; Tao L; Bin Y; Peng H; Lei B
    Inflamm Res; 2017 Jun; 66(6):523-534. PubMed ID: 28361293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulating of ocular inflammation with macrophage migration inhibitory factor is associated with notch signalling in experimental autoimmune uveitis.
    Yang H; Zheng S; Mao Y; Chen Z; Zheng C; Li H; Sumners C; Li Q; Yang P; Lei B
    Clin Exp Immunol; 2016 Feb; 183(2):280-93. PubMed ID: 26400205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cell-permeable peptide inhibitor of p55PIK signaling alleviates ocular inflammation in mouse models of uveitis.
    Zhu M; Yang H; Chen Z; Xia X; Deng Q; Shen Y
    Exp Eye Res; 2020 Oct; 199():108180. PubMed ID: 32777209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caffeic acid phenethyl ester lessens disease symptoms in an experimental autoimmune uveoretinitis mouse model.
    Choi JH; Roh KH; Oh H; Park SJ; Ha SM; Kang MS; Lee JH; Jung SY; Song H; Yang JW; Park S
    Exp Eye Res; 2015 May; 134():53-62. PubMed ID: 25795054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral administration of retinoic acid receptor-alpha/beta-specific ligand Am80 suppresses experimental autoimmune uveoretinitis.
    Keino H; Watanabe T; Sato Y; Okada AA
    Invest Ophthalmol Vis Sci; 2011 Mar; 52(3):1548-56. PubMed ID: 20861477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of leflunomide on experimental autoimmune uveitis in Lewis rats].
    Fang C; Zhou D; Zhan S; He Y; Lin Z; Huang C; Li J
    Zhonghua Yan Ke Za Zhi; 2015 Oct; 51(10):754-61. PubMed ID: 26693771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amelioration of experimental autoimmune uveitis by leflunomide in Lewis rats.
    Fang CB; Zhou DX; Zhan SX; He Y; Lin Z; Huang C; Li J
    PLoS One; 2013; 8(4):e62071. PubMed ID: 23626769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KS23, a novel peptide derived from adiponectin, inhibits retinal inflammation and downregulates the proportions of Th1 and Th17 cells during experimental autoimmune uveitis.
    Niu T; Cheng L; Wang H; Zhu S; Yang X; Liu K; Jin H; Xu X
    J Neuroinflammation; 2019 Dec; 16(1):278. PubMed ID: 31883532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Analysis of the Interphotoreceptor Retinoid Binding ProteinInduced Models of Experimental Autoimmune Uveitis in B10.RIII versus C57BL/6 Mice.
    Chen Y; Chen Z; Chong WP; Wu S; Wang W; Zhou H; Chen J
    Curr Mol Med; 2018; 18(9):602-611. PubMed ID: 30636608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vorinostat Modulates the Imbalance of T Cell Subsets, Suppresses Macrophage Activity, and Ameliorates Experimental Autoimmune Uveoretinitis.
    Fang S; Meng X; Zhang Z; Wang Y; Liu Y; You C; Yan H
    Neuromolecular Med; 2016 Mar; 18(1):134-45. PubMed ID: 26798022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SLAT/Def6 plays a critical role in the pathogenic process of experimental autoimmune uveitis (EAU).
    Vistica BP; Shi G; Nugent L; Tan C; Altman A; Gery I
    Mol Vis; 2012; 18():1858-64. PubMed ID: 22815639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The requirement for pertussis to induce EAU is strain-dependent: B10.RIII, but not B10.A mice, develop EAU and Th1 responses to IRBP without pertussis treatment.
    Silver PB; Chan CC; Wiggert B; Caspi RR
    Invest Ophthalmol Vis Sci; 1999 Nov; 40(12):2898-905. PubMed ID: 10549650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amelioration of experimental autoimmune uveoretinitis with nuclear factor-{kappa}B Inhibitor dehydroxy methyl epoxyquinomicin in mice.
    Iwata D; Kitaichi N; Miyazaki A; Iwabuchi K; Yoshida K; Namba K; Ozaki M; Ohno S; Umezawa K; Yamashita K; Todo S; Ishida S; Onoé K
    Invest Ophthalmol Vis Sci; 2010 Apr; 51(4):2077-84. PubMed ID: 19907030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of DR3 expression in CD4⁺ T cells promotes secretion of IL-17 in experimental autoimmune uveitis.
    Qin T
    Mol Vis; 2011; 17():3486-93. PubMed ID: 22219644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S-nitrosoglutathione prevents interphotoreceptor retinoid-binding protein (IRBP(161-180))-induced experimental autoimmune uveitis.
    Haq E; Rohrer B; Nath N; Crosson CE; Singh I
    J Ocul Pharmacol Ther; 2007 Jun; 23(3):221-31. PubMed ID: 17593005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CTLA4-Ig suppresses development of experimental autoimmune uveitis in the induction and effector phases: Comparison with blockade of interleukin-6.
    Iwahashi C; Fujimoto M; Nomura S; Serada S; Nakai K; Ohguro N; Nishida K; Naka T
    Exp Eye Res; 2015 Nov; 140():53-64. PubMed ID: 26297802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aminooxy-Acetic Acid Inhibits Experimental Autoimmune Uveitis by Modulating the Balance between Effector and Regulatory Lymphocyte Subsets.
    Mei S; Huang Y; Li N; Xu Z; Xu J; Dai Q; Wu J; Kijlstra A; Yang P; Hou S
    Curr Mol Med; 2020; 20(8):624-632. PubMed ID: 32072910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.